Schmidt Martina E, Meynköhn Anna, Habermann Nina, Wiskemann Joachim, Oelmann Jan, Hof Holger, Wessels Sabine, Klassen Oliver, Debus Jürgen, Potthoff Karin, Steindorf Karen, Ulrich Cornelia M
Division of Preventive Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
Division of Preventive Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):329-37. doi: 10.1016/j.ijrobp.2015.10.058. Epub 2015 Nov 2.
To explore the mediating role of inflammatory parameters in the development of fatigue, pain, and potentially related depressive symptoms during radiation therapy for breast cancer and its mitigation by resistance exercise.
Breast cancer patients scheduled for adjuvant radiation therapy were randomized to 12-week progressive resistance exercise training (EX) or a relaxation control group. Interleukin-6 (IL-6) and interleukin-1 receptor antagonist (IL-1ra) were measured in serum samples collected before, at the end, and 6 weeks after radiation therapy from 103 chemotherapy-naïve participants. Fatigue was assessed with the multidimensional Fatigue Assessment Questionnaire, pain with the European Organization for Research and Treatment of Cancer QLQ-C30, and depressive symptoms with the Center for Epidemiologic Studies Depression Scale. Analysis of covariance models, partial correlations, Freedman-Schatzkin tests, and R(2) effect-size measures for mediation were calculated.
The analysis of covariance models revealed a significant intervention effect on IL-6 (P=.010) and the IL-6/IL-1ra ratio (P=.018), characterized by a marked increase during radiation therapy among controls, but no significant change in EX. Interleukin-1 receptor antagonist did not change significantly in either group (P=.88). Increased IL-6 and IL-6/IL-1ra levels at the end of radiation therapy were significantly associated with increased physical fatigue and pain 6 weeks after radiation. We observed significant partial mediation by IL-6 and IL-6/IL-1ra of the effect of resistance exercise on physical fatigue (Freedman-Schatzkin P=.023 and P<.001) and pain (both P<.001). Hereby IL-6 and IL-6/IL-1ra mediated between 15% and 24% of the variance of physical fatigue and pain explained by the intervention.
This randomized, controlled trial showed a significantly increased proinflammatory cytokine level after adjuvant radiation therapy in breast cancer patients. This effect was counteracted by progressive resistance exercise training. Interleukin-6 and the IL-6/IL-1ra ratio seemed to mediate the beneficial effect of exercise on physical fatigue and pain but only to a small extent.
探讨炎症参数在乳腺癌放射治疗期间疲劳、疼痛及潜在相关抑郁症状发展过程中的中介作用,以及抗阻运动对其的缓解作用。
计划接受辅助放射治疗的乳腺癌患者被随机分为12周渐进性抗阻运动训练组(EX)或放松对照组。在放疗前、结束时及结束后6周,从103名未接受过化疗的参与者采集的血清样本中检测白细胞介素-6(IL-6)和白细胞介素-1受体拮抗剂(IL-1ra)。使用多维疲劳评估问卷评估疲劳,用欧洲癌症研究与治疗组织QLQ-C30评估疼痛,并用流行病学研究中心抑郁量表评估抑郁症状。计算协方差分析模型、偏相关、弗里德曼-沙茨金检验以及中介作用的R(2)效应量指标。
协方差分析模型显示,干预对IL-6(P = 0.010)和IL-6/IL-1ra比值(P = 0.018)有显著影响,其特征是对照组放疗期间显著升高,而EX组无显著变化。两组中IL-1ra均无显著变化(P = 0.88)。放疗结束时IL-6和IL-6/IL-1ra水平升高与放疗后6周身体疲劳和疼痛增加显著相关。我们观察到IL-6和IL-6/IL-1ra对抗阻运动对身体疲劳(弗里德曼-沙茨金检验P = 0.023和P < 0.001)和疼痛(两者P < 0.001)的影响有显著的部分中介作用。据此,IL-6和IL-6/IL-1ra介导了干预所解释的身体疲劳和疼痛变异的15%至24%。
这项随机对照试验表明,乳腺癌患者辅助放疗后促炎细胞因子水平显著升高。渐进性抗阻运动训练可抵消这种效应。白细胞介素-6和IL-6/IL-1ra比值似乎介导了运动对身体疲劳和疼痛的有益作用,但程度较小。